(Q39698718)

14 September 2017

title

Non-parenteral combined afterload and preload reduction therapy in congestive heart failure (English)

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

Cardiology and cardiovascular medicine

30 April 2022

main subject

heart failure

0 references

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

30 April 2022

congestive heart failure

1 reference

J. Mehta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116791

30 April 2022

C. J. Pepine

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116791

30 April 2022

C. R. Conti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A116791

30 April 2022

language of work or name

1 reference

1 August 1978

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fclc.4960010203

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.4960010203/fullpdf

30 April 2022

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

30 April 2022

1 reference

14 September 2017

volume

1

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

68-73

1 reference

Nitroglycerin ointment in acute myocardial infarction

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Oral hydralazine therapy for chronic refractory heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

The role of vasodilator therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Measurement of blood flow by thermodilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Medical intelligence drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Direct and reflex cardiostimulating effects of hydralazine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Phentolamine for vasodilator treatment of severe heart-failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960010203

7 January 2021

British Journal of Pharmacology

4

20

123

Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine (English)

author name string

Brunner

publication date

1967

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

30 April 2022

21

26

0 references

A study of the mechanism of the hemodynamic effects of hydralazine in man

1

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine

29 November 2022

4

1 reference

https://api.crossref.org/works/10.1002/CLC.4960010203

29 November 2022

Identifiers

1 reference

14 September 2017

1 reference